Stock Taper 
MEDS
$1.37
▼ DOWN 5.52% (-0.08)
KEY STATISTICS
Market Cap$3.59 M
52w High$97.50
52w Low$1.25
Dividend Yield—
Frequency—
P/E—
Volume69.61K
Shares Out.2.62M
COMPANY
LEADERSHIP
CHIEF EXECUTIVE
Prashant Patel
ABOUT
SECTOR
Healthcare
WENT PUBLIC
February 21, 2025
METHOD OF GOING PUBLIC
IPO
FULL TIME EMPLOYEES
31
SPLIT RECORD
| DATE | TYPE | RATIO |
|---|---|---|
| 2026-07-16 | Reverse | 1:50 |
| 2026-05-26 | Reverse | 1:50 |
PRICE
$1.37 ▼ DOWN 5.52% (−$0.08)About DataMEDS AI, Inc.
https://datamedsai.com ↗DataMEDS AI is a Health IT company integrating technology, pharmacy, and telemedicine using AI platform EinsteinRx™ and blockchain-based PharmacyChain™ to optimize prescription reimbursement and dispensing.
INDUSTRY
Medical - Distribution
A PRODUCT DATAMEDS AI, INC. IS KNOWN FOR
Health Lives Here app
A patient-facing mobile app by DataMEDS AI that consolidates health data using AI and blockchain, empowering patients with control, revenue participation, and tailored solutions for conditions like muscle loss and Long COVID.
Revenue by Products
| Icon | PRODUCT | Q1-2025 | Q2-2025 | Q3-2025 | Q4-2025 |
|---|---|---|---|---|---|
 | Product | $10.67M | $7.55M ▼ | $2.64M ▼ | $1.01M ▼ |
ETFS HOLDING THIS STOCK
ETFS HOLDING
11
LISTED HERE
1
RANKED BY POSITION SIZE
RATINGS SNAPSHOT
Overall rating: C
Discounted Cash Flow1
Return On Equity5
Return On Assets1
Debt To Equity1
Price To Earnings1
Price To Book1
Overall Score2
INSIDER TRADES
★
DIRECTOR
AJJARAPU SURENDRA K
Purchase · 5.0M shares
2026-03-31
★
DIRECTOR
AJJARAPU SURENDRA K
Purchase · 100.0K shares
2026-06-22
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Patel Prashant
Purchase · 100.0K shares
2026-06-22
★
DIRECTOR, OFFICER: CHIEF EXECUTIVE OFFICER
Patel Prashant
Purchase · 100.0K shares
2026-06-22
SECTORS PEERS
| PEER | PRICE | |
|---|---|---|
 BDSX | $26.63 | COMPARE |
 OKUR | $3.94 | COMPARE |
 INMB | $2.32 | COMPARE |
 XLO | $9.23 | COMPARE |
 ALGS | $6.67 | COMPARE |
 TELA | $0.65 | COMPARE |
 BEAT | $0.49 | COMPARE |